Merck exec says company is discussing use of COVID antiviral drug in Ebola response

Merck is in discussions with various global health authorities about making its COVID antiviral pill, molnupiravir, available as an Ebola treatment to address the widening outbreak in the Democratic Republic of Congo, a senior executive told Reuters.

Original source: MyJoyOnline Ghana